查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594382

多重检测市场：按产品/服务、类型、技术、应用、最终用户 - 2025-2030 年全球预测

Multiplex Assays Market by Product & Service (Consumables, Instruments, Software & Services), Type (Cell-Based Multiplex Assays, Nucleic Acid Multiplex Assays, Protein Multiplex Assays), Technology, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023 年多重检测市场价值为 38.9 亿美元，预计到 2024 年将达到 42.1 亿美元，复合年增长率为 8.50%，到 2030 年将达到 68.8 亿美元。

多重检测是一种诊断工具，可以同时检测和定量一个样品中的多种分析物，从而提高通量和资料准确性。对多重检测的需求源于其简化生物技术、药物开发和临床诊断工作流程的能力，并且已被证明对于个人化医疗、疾病分析和生物标记发现等应用至关重要。这些检测方法已广泛应用于肿瘤学、自体免疫疾病、感染疾病和过敏测试等领域。主要成长动力包括慢性病盛行率的增加、对就地检验的需求以及蛋白质体学和基因组学的进步。技术的进步、伴同性诊断的更大接受度以及生物标记识别研究的扩展也为市场扩张铺平了道路。然而，市场面临着高成本、严格的法规环境以及检测设计和资料解释的复杂性等限制。为了利用这个机会，建议投资自动化、创新检测平台以及与研究和医疗机构的合作。单细胞分析和资料分析人工智慧整合等新兴领域为创新提供了肥沃的土壤。该市场的特点是主要企业之间的竞争侧重于技术增强和策略联盟。研究工作可以集中于开发具有成本效益且易于使用的平台，以保持高灵敏度和特异性。为了克服挑战并利用快速成长的商机，公司必须优先考虑研发，包括改进检测技术、开发用户友好的介面以及扩展可检测分析物的种类。解决与现有实验室工作流程的互通性等限制以及克服复杂生物样品所带来的分析挑战至关重要。总体而言，在不断变化的医疗需求和技术进步的支持下，多重检测市场预计将出现强劲增长，战略重点是业务扩展所必需的创新和协作。

主要市场统计
基准年[2023] 38.9亿美元
预测年份 [2024] 42.1亿美元
预测年份 [2030] 68.8亿美元
复合年增长率（%） 8.50%

市场动态：揭示快速发展的多重检测市场的关键市场洞察

供需的动态交互作用正在改变多重检测市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 慢性病和感染疾病增加，快速转向早期诊断
    • 高度个人化药物的使用迅速增加
    • 扩大多重测定在药物开发的应用
  • 市场限制因素
    • 多重检测的复杂性和设备高成本
  • 市场机会
    • 多重技术在临床诊断上的兴起
    • 在临床环境中采用自动化设备和装置的可能性
  • 市场问题
    • 缺乏熟练且经验丰富的医疗专业人员

波特五力：驾驭多重检测市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解多重侦测市场的外部影响

外部宏观环境因素在塑造多重侦测市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解多重检测市场的竞争格局

对多重检测市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：多重侦测市场供应商的绩效评估

FPNV 定位矩阵是评估多重侦测市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製多重检测市场的成功之路

多重检测市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争格局中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病和感染疾病增加，快速转向早期诊断
      • 个人化精准医疗的使用快速成长
      • 扩大多种检测方法在药物开发的应用
    • 抑制因素
      • 多重测定的相关复杂性和设备的高成本
    • 机会
      • 临床诊断中的多重检测新技术
      • 在临床环境中引入自动化设备和装置的可能性
    • 任务
      • 缺乏技术精湛、经验丰富的医护人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章多重检测市场：依产品与服务分类

  • 介绍
  • 消耗品
  • 装置
  • 软体和服务

第七章多重检测市场：依类型

  • 介绍
  • 基于细胞的多重检测
  • 核酸多重检测
    • 以微珠为基础的核酸检测
    • 平面核酸测定
  • 蛋白质多重检测
    • 以微珠为基础的蛋白质检测
    • 平面蛋白质测定

第八章多重检测市场：依技术分类

  • 介绍
  • 流式细胞技术
  • 萤光侦测
  • 发光
  • 多重即时流式细胞技术
  • 多重即时PCR

第九章多重检测市场：依应用分类

  • 介绍
  • 临床诊断
    • 自体免疫疾病
    • 癌症
    • 心血管疾病
    • 感染疾病
    • 代谢及内分泌疾病
    • 神经系统疾病
  • 研究与开发
    • 生物标记的发现与检验
    • 药物发现与开发

第 10 章多重检测市场：依最终用户分类

  • 介绍
  • 医院/研究所
  • 製药和生物技术公司
  • 参考实验室

第十一章美洲多重检测市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太多重检测市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的多重检测市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Abcam PLC
  • Agilent Technologies, Inc.
  • Antigenix America, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Cayman Chemical Company
  • Charles River Laboratories
  • Enfer Group
  • Enzo Life Sciences, Inc.
  • Eve Technologies Corp.
  • Flagship Biosciences Inc.
  • Future Diagnostics Solutions BV
  • Gnome Diagnostics and Gnome Sciences
  • Illumina, Inc.
  • Merck KGaA
  • MESO SCALE DIAGNOSTICS, LLC
  • Novatein Biosciences Inc.
  • PerkinElmer, Inc.
  • Protavio Ltd.
  • Siemens Healthineers AG
  • Solis BioDyne OU
  • Thermo Fisher Scientific Inc.
Product Code: MRR-8201ABF20BB9

The Multiplex Assays Market was valued at USD 3.89 billion in 2023, expected to reach USD 4.21 billion in 2024, and is projected to grow at a CAGR of 8.50%, to USD 6.88 billion by 2030.

Multiplex assays are diagnostic tools that allow for the simultaneous detection and quantification of multiple analytes in a single sample, enhancing throughput and data accuracy. The necessity of multiplex assays arises from their ability to streamline workflows in biotechnology, pharmaceutical development, and clinical diagnostics, proving essential for applications like personalized medicine, disease profiling, and biomarker discovery. These assays find extensive end-use in oncology, autoimmune diseases, infectious diseases, and allergy testing, among others. Key growth drivers include the increasing prevalence of chronic diseases, the demand for point-of-care testing, and advances in proteomics and genomics. Technological advancements, growing acceptance of companion diagnostics, and expanding research in biomarker identification further pave the way for market expansion. Nevertheless, the market faces constraints such as high costs, stringent regulatory environments, and the complexity of assay design and data interpretation. To capitalize on opportunities, investments in automation, innovative assay platforms, and partnerships with research and healthcare institutions are recommended. Emerging niches like single-cell analysis and the integration of artificial intelligence for data analysis offer fertile ground for innovation. The market is characterized by competition among key players focusing on technological enhancements and strategic collaborations. Research efforts can be concentrated on developing cost-effective, easy-to-use platforms that maintain high sensitivity and specificity. To overcome challenges and tap into burgeoning opportunities, companies must prioritize research and development to refine assay technologies, foster user-friendly interfaces, and expand the repertoire of detectable analytes. Addressing limitations like interoperability with existing laboratory workflows and overcoming the analytical challenges posed by complex biological samples will be crucial. Overall, the market for multiplex assays is poised for robust growth, underpinned by evolving healthcare needs and technological progress, with a strategic emphasis on innovation and collaboration essential for business expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 3.89 billion
Estimated Year [2024] USD 4.21 billion
Forecast Year [2030] USD 6.88 billion
CAGR (%) 8.50%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Multiplex Assays Market

The Multiplex Assays Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising chronic and infectious disease and rapid shift towards early diagnosis
    • Surge in usage of personalized-precision medications
    • Growing application of multiple assays in drug development
  • Market Restraints
    • Associated shear complexity of multiplex assays and high cost of instruments
  • Market Opportunities
    • Emerging technology of multiplexing in clinical diagnostics
    • Potential adoption of automated instruments and equipment in clinical practice
  • Market Challenges
    • Shortage of skilled and experienced healthcare professionals

Porter's Five Forces: A Strategic Tool for Navigating the Multiplex Assays Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Multiplex Assays Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Multiplex Assays Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Multiplex Assays Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Multiplex Assays Market

A detailed market share analysis in the Multiplex Assays Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Multiplex Assays Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Multiplex Assays Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Multiplex Assays Market

A strategic analysis of the Multiplex Assays Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Multiplex Assays Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Agilent Technologies, Inc., Antigenix America, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cayman Chemical Company, Charles River Laboratories, Enfer Group, Enzo Life Sciences, Inc., Eve Technologies Corp., Flagship Biosciences Inc., Future Diagnostics Solutions B.V., Gnome Diagnostics and Gnome Sciences, Illumina, Inc., Merck KGaA, MESO SCALE DIAGNOSTICS, LLC, Novatein Biosciences Inc., PerkinElmer, Inc., Protavio Ltd., Siemens Healthineers AG, Solis BioDyne OU, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Multiplex Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Consumables, Instruments, and Software & Services.
  • Based on Type, market is studied across Cell-Based Multiplex Assays, Nucleic Acid Multiplex Assays, and Protein Multiplex Assays. The Nucleic Acid Multiplex Assays is further studied across Bead-Based Nucleic Acid Assays and Planar Nucleic Acid Assays. The Protein Multiplex Assays is further studied across Bead-Based Protein Assays and Planar Protein Assays.
  • Based on Technology, market is studied across Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time Flow Cytometry, and Multiplex Real-Time PCR.
  • Based on Application, market is studied across Clinical Diagnostics and Research & Development. The Clinical Diagnostics is further studied across Autoimmune Diseases, Cancer, Cardiovascular Diseases, Infectious Diseases, Metabolism & Endocrinology Disorders, and Nervous System Disorders. The Research & Development is further studied across Biomarker Discovery & Validation and Drug Discovery & Development.
  • Based on End User, market is studied across Hospitals & Research Institutes, Pharmaceutical & Biotechnology Companies, and Reference Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising chronic and infectious disease and rapid shift towards early diagnosis
      • 5.1.1.2. Surge in usage of personalized-precision medications
      • 5.1.1.3. Growing application of multiple assays in drug development
    • 5.1.2. Restraints
      • 5.1.2.1. Associated shear complexity of multiplex assays and high cost of instruments
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging technology of multiplexing in clinical diagnostics
      • 5.1.3.2. Potential adoption of automated instruments and equipment in clinical practice
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled and experienced healthcare professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Multiplex Assays Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments
  • 6.4. Software & Services

7. Multiplex Assays Market, by Type

  • 7.1. Introduction
  • 7.2. Cell-Based Multiplex Assays
  • 7.3. Nucleic Acid Multiplex Assays
    • 7.3.1. Bead-Based Nucleic Acid Assays
    • 7.3.2. Planar Nucleic Acid Assays
  • 7.4. Protein Multiplex Assays
    • 7.4.1. Bead-Based Protein Assays
    • 7.4.2. Planar Protein Assays

8. Multiplex Assays Market, by Technology

  • 8.1. Introduction
  • 8.2. Flow Cytometry
  • 8.3. Fluorescence Detection
  • 8.4. Luminescence
  • 8.5. Multiplex Real-Time Flow Cytometry
  • 8.6. Multiplex Real-Time PCR

9. Multiplex Assays Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Diagnostics
    • 9.2.1. Autoimmune Diseases
    • 9.2.2. Cancer
    • 9.2.3. Cardiovascular Diseases
    • 9.2.4. Infectious Diseases
    • 9.2.5. Metabolism & Endocrinology Disorders
    • 9.2.6. Nervous System Disorders
  • 9.3. Research & Development
    • 9.3.1. Biomarker Discovery & Validation
    • 9.3.2. Drug Discovery & Development

10. Multiplex Assays Market, by End User

  • 10.1. Introduction
  • 10.2. Hospitals & Research Institutes
  • 10.3. Pharmaceutical & Biotechnology Companies
  • 10.4. Reference Laboratories

11. Americas Multiplex Assays Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Multiplex Assays Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Multiplex Assays Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Abcam PLC
  • 3. Agilent Technologies, Inc.
  • 4. Antigenix America, Inc.
  • 5. Becton, Dickinson and Company
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Bio-Techne Corporation
  • 8. Cayman Chemical Company
  • 9. Charles River Laboratories
  • 10. Enfer Group
  • 11. Enzo Life Sciences, Inc.
  • 12. Eve Technologies Corp.
  • 13. Flagship Biosciences Inc.
  • 14. Future Diagnostics Solutions B.V.
  • 15. Gnome Diagnostics and Gnome Sciences
  • 16. Illumina, Inc.
  • 17. Merck KGaA
  • 18. MESO SCALE DIAGNOSTICS, LLC
  • 19. Novatein Biosciences Inc.
  • 20. PerkinElmer, Inc.
  • 21. Protavio Ltd.
  • 22. Siemens Healthineers AG
  • 23. Solis BioDyne OU
  • 24. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. MULTIPLEX ASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. MULTIPLEX ASSAYS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. MULTIPLEX ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. MULTIPLEX ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MULTIPLEX ASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MULTIPLEX ASSAYS MARKET DYNAMICS
  • TABLE 7. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CELL-BASED MULTIPLEX ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY BEAD-BASED NUCLEIC ACID ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PLANAR NUCLEIC ACID ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY BEAD-BASED PROTEIN ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PLANAR PROTEIN ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY FLUORESCENCE DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY LUMINESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY MULTIPLEX REAL-TIME FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY MULTIPLEX REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY METABOLISM & ENDOCRINOLOGY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY BIOMARKER DISCOVERY & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY HOSPITALS & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 153. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 162. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 180. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 189. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 190. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 198. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 199. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 207. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 208. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 216. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 217. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 235. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 236. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 244. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 245. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 253. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 254. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 262. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 263. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 271. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 272. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 280. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 281. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 283. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 289. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 290. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 292. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 298. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 299. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 300. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 301. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 307. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 308. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 309. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 310. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 316. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 317. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 318. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 319. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 325. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 326. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 327. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 328. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 329. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 332. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 333. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 334. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 335. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 336. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 337. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 338. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 339. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 340. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 341. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 342. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 343. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 201